A long-running study from Sweden’s Karolinska Institute, published in JAMA Network Open, tracked 1,865 adults over 15 years and found that those who adhered most closely to an anti-inflammatory dietary pattern had a 29% lower risk of developing dementia. The protective association held even among participants who already carried blood biomarkers or showed physical brain changes linked to Alzheimer’s disease. The finding, described by geriatrician Liron Sinvani of Northwell Health as “incredibly compelling and hopeful,” shifts the conversation from inevitability to modifiable risk, underscoring that daily nutritional choices can meaningfully alter cognitive trajectories.

The mechanism centres on chronic systemic inflammation. Ultra-processed foods—industrial formulations high in free sugars, unhealthy fats and sodium, and low in fibre and micronutrients—trigger the release of inflammatory molecules that can cross the blood-brain barrier. According to neurologist Amalia Peterson, this process activates immune cells that damage nerve tissue and accelerate the accumulation of toxic proteins such as beta-amyloid and tau. The Pan American Health Organization, an arm of the WHO, has warned that such products are nutritionally unbalanced and should not form the basis of diets. A separate review cited by researcher Barbara Rita Cardoso links ultra-processed foods to more than 30 adverse health outcomes, including cardiovascular disease, type 2 diabetes and obesity, all of which are themselves risk factors for dementia.

Viewed from Stockholm, the study’s lead author Anja Mrhar stressed that diet quality “helps mitigate risk, even when the biological odds of developing the disease are already elevated.” The recommended pattern closely mirrors the Mediterranean diet: leafy greens, colourful fruits, nuts, whole grains, legumes, lean proteins and olive oil, while minimising sugary drinks, processed meats and packaged snacks. In parallel, a separate line of research highlights the role of circadian rhythm. A recent study, reported by Indonesian media, indicates that daily exposure to bright light—natural morning sunlight or a light-therapy box—stimulates the suprachiasmatic nucleus, improving sleep quality and thereby enhancing the brain’s clearance of metabolic waste, including amyloid proteins.

These insights arrive amid growing clinical attention to symptoms that are often misattributed. Frequent tingling in hands or legs, for instance, can signal neuropathy, vitamin B12 deficiency or carpal tunnel syndrome, not merely a limb “falling asleep.” Similarly, loud, persistent snoring with breathing pauses may indicate obstructive sleep apnoea, a condition linked to hypertension, stroke and cognitive decline. Brazilian cardiologists caution that palpitations, dizziness and shortness of breath—commonly blamed on anxiety—can sometimes be the only clues to an underlying arrhythmia, especially when episodes occur at rest or without an emotional trigger.

The next factual milestone will be interventional trials designed to test whether prescribing an anti-inflammatory diet can directly slow or prevent cognitive decline, moving beyond observational associations. In the meantime, front-of-package warning labels, already adopted in several Latin American countries, continue to be debated as a policy tool to curb consumption of ultra-processed foods.